Verona Pharma PLC
VRNA106.690USD
0.000
終値 09/26, 16:00（ET）15分遅れの株価
73.40B時価総額
損失額直近12ヶ月PER
詳細情報 企業名
企業情報
企業コードVRNA
会社名Verona Pharma PLC
上場日Mar 30, 2005
最高経営責任者「CEO」Dr. David S. Zaccardelli, Pharm.D.
従業員数209
証券種類Depository Receipt
決算期末Mar 30
本社所在地Riverside
都市LONDON
証券取引所NASDAQ Global Market Consolidated
国United Kingdom
郵便番号SE1 2RE
電話番号442032834200
ウェブサイトhttps://www.veronapharma.com/
企業コードVRNA
上場日Mar 30, 2005
最高経営責任者「CEO」Dr. David S. Zaccardelli, Pharm.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
175.14K
-66.98%
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
61.24K
-90.96%
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
14.74K
--
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
11.76K
-84.20%
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
11.68K
-84.01%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
10.61K
-84.92%
Mr. Michael Austwick
Mr. Michael Austwick
Non-Executive Independent Director
Non-Executive Independent Director
1.59K
--
Dr. Kathleen Rickard, M.D.
Dr. Kathleen Rickard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christina Ackermann
Ms. Christina Ackermann
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Martin William Edwards, M.D.
Dr. Martin William Edwards, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
175.14K
-66.98%
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
61.24K
-90.96%
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
14.74K
--
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
11.76K
-84.20%
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
11.68K
-84.01%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
10.61K
-84.92%
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
株主統計
種類
株主統計
株主統計
比率
Janus Henderson Investors
7.12%
Perceptive Advisors LLC
6.39%
Darwin Global Management Ltd
4.79%
Frazier Life Sciences Management, L.P.
3.93%
Ali (Behbahani)
3.70%
他の
74.07%
株主統計
株主統計
比率
Janus Henderson Investors
7.12%
Perceptive Advisors LLC
6.39%
Darwin Global Management Ltd
4.79%
Frazier Life Sciences Management, L.P.
3.93%
Ali (Behbahani)
3.70%
他の
74.07%
種類
株主統計
比率
Investment Advisor/Hedge Fund
26.68%
Hedge Fund
26.26%
Investment Advisor
18.32%
Private Equity
10.42%
Venture Capital
4.96%
Individual Investor
4.89%
Research Firm
4.38%
Family Office
1.17%
Pension Fund
0.15%
他の
2.77%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
423
82.86M
96.18%
-3.71M
2025Q1
406
83.91M
98.59%
+940.31K
2024Q4
326
71.46M
84.46%
-16.29M
2024Q3
290
72.06M
88.66%
-13.37M
2024Q2
265
71.81M
88.57%
-10.49M
2024Q1
244
72.12M
89.24%
-7.07M
2023Q4
230
69.67M
87.15%
-7.79M
2023Q3
210
67.04M
84.35%
-7.14M
2023Q2
205
65.57M
82.53%
-8.85M
2023Q1
188
68.22M
86.63%
-3.18M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Janus Henderson Investors
5.52M
6.48%
+3.85M
+230.91%
Mar 31, 2025
Perceptive Advisors LLC
6.56M
7.71%
+171.23K
+2.68%
Mar 31, 2025
Darwin Global Management Ltd
3.92M
4.61%
+3.11M
+384.08%
Mar 31, 2025
Frazier Life Sciences Management, L.P.
3.46M
4.06%
+73.90K
+2.18%
Mar 31, 2025
Ali (Behbahani)
3.19M
3.75%
+3.19M
--
Jan 16, 2025
RTW Investments L.P.
2.85M
3.35%
+1.03M
+56.44%
Mar 31, 2025
Eventide Asset Management, LLC
2.89M
3.4%
-238.69K
-7.62%
Mar 31, 2025
New Enterprise Associates (NEA)
2.69M
3.16%
-1.40M
-34.18%
Mar 31, 2025
Summit Partners Public Asset Management, LLC
2.32M
2.73%
+421.09K
+22.14%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
AltShares Merger Arbitrage ETF
4.25%
First Trust International Equity Opportunities ETF
2.06%
iShares Biotechnology ETF
0.5%
Fidelity Nasdaq Composite Index ETF
0.03%
AltShares Merger Arbitrage ETF
比率4.25%
First Trust International Equity Opportunities ETF
比率2.06%
iShares Biotechnology ETF
比率0.5%
Fidelity Nasdaq Composite Index ETF
比率0.03%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
